Sonoma Pharmaceuticals (SNOA) Operating Income (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted Operating Income of -$40000.0 for Q2 2026, up 88.6% on a QoQ basis from -$351000.0 in Q1 2026, and up 96.35% year-over-year from -$20372.1 in Q2 2025.
Powered by 
Analysis
Sonoma Pharmaceuticals (SNOA) Operating Income (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals has reported Operating Income for 17 years, with the latest figure at -$40000.0 in Q2 2026.
- On a quarterly basis, Operating Income rose 96.35% year-over-year to -$40000.0 in Q2 2026; TTM through Jun 2026 was -$1.4 million, a 61.29% increase from a year earlier, with the FY2026 full-year figure at -$2.5 million, up 33.67% from the prior year.
- Operating Income was -$40000.0 for Q2 2026 at Sonoma Pharmaceuticals, up from -$351000.0 in the prior quarter.
- The five-year high for Operating Income was -$40000.0 in Q2 2026, with the low at -$3.1 million in Q1 2022.
- Average Operating Income over 5 years is -$1.0 million, with a median of -$943000.0 recorded in 2022.
- The sharpest annual moves came in 2022 and 2026: Operating Income tumbled 91.44% in 2022, then surged 96.35% in 2026.
- Over 5 years, Operating Income stood at -$1.8 million in 2022, then surged by 53.98% to -$844000.0 in 2023, then slipped by 22.16% to -$1.0 million in 2024, then surged by 34.24% to -$678000.0 in 2025, then soared by 94.1% to -$40000.0 in 2026.
- The last three Operating Income figures came in at -$40000.0 (Q2 2026), -$351000.0 (Q1 2026), and -$678000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.51 Bn | 48.65 Bn | 2.32 Bn | 663.00 Mn |
| 2 | Medline | 29.43 Bn | 26.75 Bn | 2.22 Bn | 395.00 Mn |
| 3 | West Pharmaceutical Services | 24.03 Bn | 23.60 Bn | 329.20 Mn | 179.10 Mn |
| 4 | Baxter International | 12.81 Bn | 10.66 Bn | 1.03 Bn | 217.00 Mn |
| 5 | Stevanato Group S.p.A | 5.52 Bn | 5.41 Bn | 100.91 Mn | 45.39 Mn |
| 6 | Acme United | 234.32 Mn | 229.28 Mn | 26.69 Mn | 6.83 Mn |
| 7 | Rockwell Medical | 31.09 Mn | 6.29 Mn | 3.24 Mn | -1.06 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | -5.15 Mn |
| 9 | United Health Products | 8.37 Mn | 8.34 Mn | - | -166,850.00 |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn | -40,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -40,000.00 |
| Mar 31, 2026 | -351,000.00 |
| Dec 31, 2025 | -678,000.00 |
| Sep 30, 2025 | -337,000.00 |
| Jun 30, 2025 | -1.10 Mn |
| Mar 31, 2025 | -656,000.00 |
| Dec 31, 2024 | -1.03 Mn |
| Sep 30, 2024 | -850,000.00 |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | -1.41 Mn |
| Dec 31, 2023 | -844,000.00 |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Mar 31, 2023 | -1.15 Mn |
| Dec 31, 2022 | -1.83 Mn |
| Sep 30, 2022 | -731,000.00 |
| Jun 30, 2022 | -855,000.00 |
| Mar 31, 2022 | -3.06 Mn |
| Dec 31, 2021 | -958,000.00 |
| Sep 30, 2021 | -964,000.00 |